Literature DB >> 21813874

Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Lakshmi Pulakat1, Vincent G DeMarco, Sivakumar Ardhanari, Anand Chockalingam, Rukhsana Gul, Adam Whaley-Connell, James R Sowers.   

Abstract

In conditions of overnutrition, cardiac cells must cope with a multitude of extracellular signals generated by changes in nutrient load (glucose, amino acids, and lipids) and the hormonal milieu [increased insulin (INS), ANG II, and adverse cytokine/adipokine profile]. Herein, we review the diverse compensatory/adaptive mechanisms that counter the deleterious effects of excess nutrients and growth factors. We largely focus the discussion on evidence obtained from Zucker obese (ZO) and Zucker diabetic fatty (ZDF) rats, which are useful models to evaluate adaptive and maladaptive metabolic, structural, and functional cardiac remodeling. One adaptive mechanism present in the INS-resistant ZO, but absent in the diabetic ZDF heart, involves an interaction between the nutrient sensor kinase mammalian target of rapamycin complex 1 (mTORC1) and ANG II-type 2 receptor (AT2R). Recent evidence supports a cardioprotective role for the AT2R; for example, suppression of AT2R activation interferes with antihypertrophic/antifibrotic effects of AT1R blockade, and AT2R agonism improves cardiac structure and function. We propose a scenario, whereby mTORC1-signaling-mediated increase in AT2R expression in the INS-resistant ZO heart is a cardioprotective adaptation to overnutrition. In contrast to the ZO rat, heart tissues of ZDF rats do not show activation of mTORC1. We posit that such a lack of activation of the mTOR↔AT2R integrative pathway in cardiac tissue under conditions of obesity-induced diabetes may be a metabolic switch associated with INS deficiency and clinical diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813874      PMCID: PMC3289980          DOI: 10.1152/ajpregu.00316.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  116 in total

1.  Tei-index in symptomatic patients with primary and secondary mitral regurgitation.

Authors:  Christian Bruch; Axel Schmermund; Nikolaos Dagres; Marc Katz; Thomas Bartel; Raimund Erbel
Journal:  Int J Cardiovasc Imaging       Date:  2002-04       Impact factor: 2.357

2.  Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.

Authors:  E J Henriksen; S Jacob; T R Kinnick; M K Teachey; M Krekler
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

Review 3.  Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.

Authors:  M A Alpert
Journal:  Am J Med Sci       Date:  2001-04       Impact factor: 2.378

4.  A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat.

Authors:  S C Griffen; J Wang; M S German
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

5.  Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats.

Authors:  J J Luiken; Y Arumugam; D J Dyck; R C Bell; M M Pelsers; L P Turcotte; N N Tandon; J F Glatz; A Bonen
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

Review 6.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

Authors:  Dan Sorescu; Kathy K Griendling
Journal:  Congest Heart Fail       Date:  2002 May-Jun

7.  High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass.

Authors:  J Y Kim; L A Nolte; P A Hansen; D H Han; K Ferguson; P A Thompson; J O Holloszy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-12       Impact factor: 3.619

8.  Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase.

Authors:  A Kessler; I Uphues; D M Ouwens; M Till; J Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-01       Impact factor: 4.310

9.  A novel mouse model of lipotoxic cardiomyopathy.

Authors:  H C Chiu; A Kovacs; D A Ford; F F Hsu; R Garcia; P Herrero; J E Saffitz; J E Schaffer
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

10.  Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function.

Authors:  G G Serneri; M Boddi; I Cecioni; S Vanni; M Coppo; M L Papa; B Bandinelli; I Bertolozzi; G Polidori; T Toscano; M Maccherini; P A Modesti
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

View more
  25 in total

Review 1.  In scarcity and abundance: metabolic signals regulating cell growth.

Authors:  Shady Saad; Matthias Peter; Reinhard Dechant
Journal:  Physiology (Bethesda)       Date:  2013-09

2.  Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

Authors:  Annayya R Aroor; James R Sowers; Shawn B Bender; Ravi Nistala; Mona Garro; Irina Mugerfeld; Melvin R Hayden; Megan S Johnson; Muhammad Salam; Adam Whaley-Connell; Vincent G Demarco
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

Review 3.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

Review 4.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

Review 5.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

6.  Aldosterone and Risk for Insulin Resistance.

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

Review 7.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

8.  RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.

Authors:  Rukhsana Gul; Maya Ramdas; Chirag H Mandavia; James R Sowers; Lakshmi Pulakat
Journal:  Cardiorenal Med       Date:  2012-10-27       Impact factor: 2.041

9.  Phosphoprotein Phosphatase PP2A Regulation of Insulin Receptor Substrate 1 and Insulin Metabolic Signaling.

Authors:  Chirag Mandavia; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-11-16       Impact factor: 2.041

10.  Regulation of Overnutrition-Induced Cardiac Inflammatory Mechanisms.

Authors:  Rukhsana Gul; Vincent G Demarco; James R Sowers; Adam Whaley-Connell; Lakshmi Pulakat
Journal:  Cardiorenal Med       Date:  2012-07-24       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.